{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:42:58Z","timestamp":1791474178403,"version":"4.3.4"},"reference-count":64,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Metabolic dysfunction-associated fatty liver disease (MASLD) is a chronic, non-communicable spectrum of diseases characterized by lipid accumulation. It is often asymptomatic, and its prevalence varies by region, age, gender, and economic status. It is estimated that 25% of the world\u2019s population currently suffer from MAFLD, and 20 million patients will die from MAFLD-related diseases. In the last 20 years, tea and anti-obesity research have indicated that regularly consuming tea decreases the risk of cardiovascular disease, stroke, obesity, diabetes, and metabolic syndrome (MeS). In this review, we aimed to present studies concerning the influence of matcha extracts and epigallocatechin-3 gallate (EGCG) supplements on metabolic functions in the context of MAFLD in human and animal studies. The published data show promise. In both human and animal studies, the beneficial effects on body weight, cholesterol levels, and liver metabolism and function were noted, even in short-period experiments. The safety levels for EGCG and green tea extract consumption are marked. More experiments are needed to confirm the results observed in animal studies and to show the mechanisms by which green tea exerts its effects. The preliminary data from research concerning microbiota or epigenetic changes observed after polyphenols and green tea consumption need to be expanded. To improve the efficiency and availability of green tea or supplement consumption as a treatment for MAFLD patients, more research with larger groups and longer study durations is needed.<\/jats:p>","DOI":"10.3390\/nu17152532","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:51:41Z","timestamp":1754038301000},"page":"2532","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Matcha and Tea Catechins on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)\u2014A Review of Patient Trials and Animal Studies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-5493","authenticated-orcid":false,"given":"Danuta I.","family":"Kosik-Bogacka","sequence":"first","affiliation":[{"name":"Department of Biology, Parasitology and Pharmaceutical Botany, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-0830","authenticated-orcid":false,"given":"Katarzyna","family":"Piotrowska","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2147\/DMSO.S304357","article-title":"Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease","volume":"14","author":"Machado","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Marques, P., Francisco, V., Mart\u00ednez-Arenas, L., Carvalho-Gomes, \u00c2., Domingo, E., Piqueras, L., Berenguer, M., and Sanz, M.J. (2023). Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032313"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20420188241252543","DOI":"10.1177\/20420188241252543","article-title":"MAFLD: An ideal framework for understanding disease phenotype in individuals of normal weight","volume":"15","author":"Pan","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/CIA.S295524","article-title":"NAFLD in the elderly","volume":"16","author":"Alqahtani","year":"2021","journal-title":"Clin. Interv. Aging."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: Heterogeneous associations with metabolic changes","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Riazi, K., Swain, M.G., Congly, S.E., Kaplan, G.G., and Shaheen, A.A. (2022). Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): A narrative review. Nutrients, 14.","DOI":"10.3390\/nu14214556"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4254\/wjh.v13.i11.1584","article-title":"Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity","volume":"13","author":"Pal","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/liv.15322","article-title":"Contribution of a genetic risk score to ethnic differences in fatty liver disease","volume":"42","author":"Kubiliun","year":"2022","journal-title":"Liver Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Darci-Maher, N., Alvarez, M., Arasu, U.T., Selvarajan, I., Lee, S.H.T., Pan, D.Z., Miao, Z., Das, S.S., Kaminska, D., and \u00d6rd, T. (2023). Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease. EBioMedicine, 92.","DOI":"10.1016\/j.ebiom.2023.104620"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Della Torre, S. (2020). Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.572490"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Associazione Italiana per lo Studio del Fegato (AISF), Societ\u00e0 Italiana di Diabetologia (SID), and Societ\u00e0 Italiana dell\u2019Obesit\u00e0 (SIO) (2022). Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). Eat. Weight. Disord., 27, 1603\u20131619. Erratum in Eat. Weight. Disord. 2023, 28, 27.","DOI":"10.1007\/s40519-021-01287-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3350\/cmh.2023.0035","article-title":"Association of visceral fat obesity, sarcopenia, and myosteatosis with non-alcoholic fatty liver disease without obesity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/oby.22432","article-title":"Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults","volume":"27","author":"Jiang","year":"2019","journal-title":"Obesity"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bahitham, W., Alghamdi, S., Omer, I., Alsudais, A., Hakeem, I., Alghamdi, A., Abualnaja, R., Sanai, F.M., Rosado, A.S., and Sergi, C.M. (2024). Double trouble: How microbiome dysbiosis and mitochondrial dysfunction drive non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030550"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vallianou, N., Christodoulatos, G.S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., and Dalamaga, M. (2021). Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: Current evidence and perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12010056"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2482158","DOI":"10.1080\/21505594.2025.2482158","article-title":"Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease","volume":"16","author":"Zhang","year":"2025","journal-title":"Virulence"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10068-022-01069-0","article-title":"The roles of catechins in regulation of systemic inflammation","volume":"31","author":"Kim","year":"2022","journal-title":"Food Sci. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sokary, S., Zakaria, Z., Bawadi, H., and Al-Asmakh, M. (2023). Testing the anticancer effect of matcha using zebrafish as an animal model. Nutrients, 15.","DOI":"10.3390\/nu15102369"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, S., Fan, B., Li, X., and Sun, G. (2024). Global hotspots and trends in tea anti-obesity research: A bibliometric analysis from 2004 to 2024. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1496582"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.12.013","article-title":"Weight control and prevention of metabolic syndrome by green tea","volume":"64","author":"Grove","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Rha, C.S., Jung, Y.S., Lee, J.D., Jang, D., Kim, M.S., Lee, M.S., Hong, Y.D., and Kim, D.O. (2020). Chemometric analysis of extracts and fractions from green, oxidized, and microbial fermented teas and their correlation to potential antioxidant and anticancer effects. Antioxidants, 9.","DOI":"10.3390\/antiox9101015"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1007\/s13197-021-05086-5","article-title":"Matcha and Sencha green tea extracts with regard to their phenolics pattern and antioxidant and antidiabetic activity during in vitro digestion","volume":"58","author":"Rusak","year":"2021","journal-title":"J. Food Sci. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes, M., Aggett, P., Aguilar, F., Crebelli, R., Dusemund, B., Filipi\u010d, M., Frutos, M.J., Galtier, P., and Gott, D. (2018). Scientific opinion on the safety of green tea catechins. EFSA J., 16, e05239.","DOI":"10.2903\/j.efsa.2018.5239"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100823","DOI":"10.1016\/j.crfs.2024.100823","article-title":"Matcha alleviates obesity by modulating gut microbiota and its metabolites","volume":"9","author":"Luo","year":"2024","journal-title":"Curr. Res. Food Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rahman, S.U., Huang, Y., Zhu, L., Chu, X., Junejo, S.A., Zhang, Y., Khan, I.M., Li, Y., Feng, S., and Wu, J. (2020). Tea polyphenols attenuate liver inflammation by modulating obesity-related genes and down-regulating COX-2 and iNOS expression in high fat-fed dogs. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02448-7"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhou, D.-D., Mao, Q.-Q., Li, B.-Y., Saimaiti, A., Huang, S.-Y., Xiong, R.-G., Shang, A., Luo, M., Li, H.-Y., and Gan, R.-Y. (2022). Effects of different green teas on obesity and non-alcoholic fatty liver disease induced by a high-fat diet in mice. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.929210"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"James, A., Wang, K., and Wang, Y. (2023). Therapeutic activity of green tea epigallocatechin-3-gallate on metabolic diseases and non-alcoholic fatty liver diseases: The current updates. Nutrients, 15.","DOI":"10.3390\/nu15133022"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Capasso, L., De Masi, L., Sirignano, C., Maresca, V., Basile, A., Nebbioso, A., Rigano, D., and Bontempo, P. (2025). Epigallocatechin gallate (EGCG): Pharmacological properties, biological activities and therapeutic potential. Molecules, 30.","DOI":"10.3390\/molecules30030654"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jakubczyk, K., Szymczykowska, K., Kika, J., Janda-Milczarek, K., Palma, J., Melkis, K., Alshekh, R., and Maciejewska-Markiewicz, D. (2024). Exploring the influence of origin, harvest time, and cultivation method on antioxidant capacity and bioactive compounds of matcha teas. Foods, 13.","DOI":"10.3390\/foods13081270"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Najman, K., Sadowska, A., Woli\u0144ska, M., Starczewska, K., and Buczak, K. (2023). The content of bioactive compounds and technological properties of matcha green tea and its application in the design of functional beverages. Molecules, 28.","DOI":"10.3390\/molecules28207018"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100396","DOI":"10.1016\/j.crfs.2022.11.015","article-title":"The therapeutic potential of matcha tea: A critical review on human and animal studies","volume":"6","author":"Sokary","year":"2022","journal-title":"Curr. Res. Food Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s11130-023-01121-2","article-title":"Catechin Composition, Phenolic Content, and Antioxidant Properties of Commercially-Available Bagged, Gunpowder, and Matcha Green Teas","volume":"78","author":"Meyer","year":"2023","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/07315724.2010.10719814","article-title":"Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome","volume":"29","author":"Basu","year":"2010","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_39","first-page":"157","article-title":"Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial","volume":"16","author":"Hsu","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S0007114511005095","article-title":"Beneficial effects of catechin-rich green tea and inulin on the body composition of overweight adults","volume":"107","author":"Yang","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jmf.2012.0062","article-title":"The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women","volume":"16","author":"Cardoso","year":"2013","journal-title":"J. Med. Food"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/jhn.12181","article-title":"Effects of green tea or green tea extract on insulin sensitivity and glycaemic control in populations at risk of type 2 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials","volume":"27","author":"Wang","year":"2014","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clnu.2015.05.003","article-title":"Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Chen","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2017.08.008","article-title":"Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial","volume":"22","author":"Mota","year":"2017","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1123\/ijsnem.2017-0237","article-title":"Matcha green tea drinks enhance fat oxidation during brisk walking in females","volume":"28","author":"Willems","year":"2018","journal-title":"Int. J. Sport. Nutr. Exerc. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Huang, L.H., Liu, C.Y., Wang, L.Y., Huang, C.J., and Hsu, C.H. (2018). Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): A randomised, double-blind, and cross-over placebo-controlled clinical trial. BMC Complement. Altern. Med., 18.","DOI":"10.1186\/s12906-018-2355-x"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/19390211.2020.1811443","article-title":"Three weeks daily intake of matcha green tea powder affects substrate oxidation during moderate-intensity exercise in females","volume":"18","author":"Willems","year":"2021","journal-title":"J. Diet. Suppl."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Roberts, J.D., Willmott, A.G.B., Beasley, L., Boal, M., Davies, R., Martin, L., Chichger, H., Gautam, L., and Del Coso, J. (2021). The impact of decaffeinated green tea extract on fat oxidation, body composition and cardio-metabolic health in overweight, recreationally active individuals. Nutrients, 13.","DOI":"10.3390\/nu13030764"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11130-022-00998-9","article-title":"A prospective non-randomized open-label comparative study of the effects of matcha tea on overweight and obese individuals: A pilot observational study","volume":"77","author":"Qasem","year":"2022","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3164\/jcbn.22-81","article-title":"A randomized, double-blinded study evaluating effect of matcha green tea on human fecal microbiota","volume":"72","author":"Morishima","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/jmf.2008.1282","article-title":"Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats","volume":"12","author":"Yamabe","year":"2009","journal-title":"J. Med. Food."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhou, J., Yu, Y., Ding, L., Xu, P., and Wang, Y. (2021). Matcha green tea alleviates non-alcoholic fatty liver disease in high-fat diet-induced obese mice by regulating lipid metabolism and inflammatory responses. Nutrients, 13.","DOI":"10.3390\/nu13061950"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yu, Y., Ding, L., Xu, P., and Zhou, J. (2022). Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.931060"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wang, J., Dong, L., Hu, J.Q., Wang, Y.Y., Li, A., Peng, B., Zhang, B.W., Liu, J.M., and Wang, S. (2022). Differential regulation and preventive mechanisms of green tea powder with different quality attributes on high-fat diet-induced obesity in mice. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.992815"},{"key":"ref_55","first-page":"e73799","article-title":"A comparative effect of different herbal products on lipid metabolism and hepatic tissue: An experimental study on a rat model","volume":"16","author":"Mohammed","year":"2024","journal-title":"Cureus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2008-7802.173051","article-title":"The Effect of green tea extract supplementation on liver enzymes in patients with non-alcoholic fatty liver disease","volume":"7","author":"Pezeshki","year":"2016","journal-title":"Int. J. Prev. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4168380","DOI":"10.1155\/2019\/4168380","article-title":"Green tea prevents NAFLD by modulation of mir-34a and mir-194 expression in a high-fat diet mouse model","volume":"2019","author":"Torres","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0955-2863(03)00054-8","article-title":"Effect of EGCG on lipid absorption and plasma lipid levels in rats","volume":"14","author":"Raederstorff","year":"2003","journal-title":"J. Nutr. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/jn\/138.9.1677","article-title":"The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice","volume":"138","author":"Bose","year":"2008","journal-title":"J. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.phymed.2009.12.006","article-title":"The antioxidant effect of green tea catechin ameliorates experimental liver injury","volume":"17","author":"Kobayashi","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"520510","DOI":"10.1155\/2012\/520510","article-title":"Catechins and caffeine inhibit fat accumulation in mice through the improvement of hepatic lipid metabolism","volume":"2012","author":"Sugiura","year":"2012","journal-title":"J. Obes."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chen, Z., Liu, B., Gong, Z., Huang, H., Gong, Y., and Xiao, W. (2022). Metagenomics approach to the intestinal microbiome structure and abundance in high-fat-diet-induced hyperlipidemic rat fed with (-)-epigallocatechin-3-gallate nanoparticles. Molecules, 27.","DOI":"10.3390\/molecules27154894"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Xu, T., Liu, R., Zhu, H., Zhou, Y., Pei, T., and Yang, Z. (2022). The inhibition of lps-induced oxidative stress and inflammatory responses is associated with the protective effect of (-)-epigallocatechin-3-gallate on bovine hepatocytes and murine liver. Antioxidants, 11.","DOI":"10.3390\/antiox11050914"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.3748\/wjg.v29.i34.5054","article-title":"Green tea polyphenols alleviate di-(2-ethylhexyl) phthalate-induced liver injury in mice","volume":"29","author":"Shi","year":"2023","journal-title":"World J. Gastroenterol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/15\/2532\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:23Z","timestamp":1760034023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/15\/2532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":64,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["nu17152532"],"URL":"https:\/\/doi.org\/10.3390\/nu17152532","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}